These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23866899)

  • 1. Effective treatment of idiopathic chronic cold urticaria with omalizumab: report of 3 cases.
    Le Moing A; Bécourt C; Pape E; Dejobert Y; Delaporte E; Staumont-Sallé D
    J Am Acad Dermatol; 2013 Aug; 69(2):e99-101. PubMed ID: 23866899
    [No Abstract]   [Full Text] [Related]  

  • 2. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.
    Metz M; Ohanyan T; Church MK; Maurer M
    JAMA Dermatol; 2014 Mar; 150(3):288-90. PubMed ID: 24477320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
    Metz M; Ohanyan T; Church MK; Maurer M
    J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of omalizumab in the treatment of chronic urticaria.
    Stitt JM; Dreskin SC
    Immunotherapy; 2014; 6(6):691-7. PubMed ID: 25186602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life experiences with omalizumab for the treatment of chronic urticaria.
    Sussman G; Hébert J; Barron C; Bian J; Caron-Guay RM; Laflamme S; Stern S
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):170-4. PubMed ID: 24468258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
    Kaplan A; Ledford D; Ashby M; Canvin J; Zazzali JL; Conner E; Veith J; Kamath N; Staubach P; Jakob T; Stirling RG; Kuna P; Berger W; Maurer M; Rosén K
    J Allergy Clin Immunol; 2013 Jul; 132(1):101-9. PubMed ID: 23810097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab (Xolair) for the treatment of chronic idiopathic urticarial.
    Scheinfeld N
    Skinmed; 2014; 12(5):294-7. PubMed ID: 25632648
    [No Abstract]   [Full Text] [Related]  

  • 8. Omalizumab (Xolair) for chronic urticaria.
    Med Lett Drugs Ther; 2013 May; 55(1417):43-4. PubMed ID: 23715129
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
    Song CH; Stern S; Giruparajah M; Berlin N; Sussman GL
    Ann Allergy Asthma Immunol; 2013 Feb; 110(2):113-7. PubMed ID: 23352531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab is effective in nonautoimmune urticaria.
    Ferrer M; Gamboa P; Sanz ML; Goikoetxea MJ; Cabrera-Freitag P; Javaloyes G; Berroa F; Kaplan AP
    J Allergy Clin Immunol; 2011 May; 127(5):1300-2. PubMed ID: 21315432
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab in chronic urticaria.
    Metz M; Maurer M
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Severe Cold-Induced Urticaria in a Child With Omalizumab.
    Alba Marín JC; Martorell Aragones A; Satorre Viejo P; Gastaldo Simeon E
    J Investig Allergol Clin Immunol; 2015; 25(4):303-4. PubMed ID: 26310049
    [No Abstract]   [Full Text] [Related]  

  • 13. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
    Maurer M; Rosén K; Hsieh HJ; Saini S; Grattan C; Gimenéz-Arnau A; Agarwal S; Doyle R; Canvin J; Kaplan A; Casale T
    N Engl J Med; 2013 Mar; 368(10):924-35. PubMed ID: 23432142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab in chronic spontaneous urticaria: patient-tailored tapering or planned discontinuation?
    Tontini C; Marinangeli L; Cognigni M; Bilò MB; Antonicelli L
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):147-8. PubMed ID: 26048249
    [No Abstract]   [Full Text] [Related]  

  • 15. Omalizumab in chronic urticaria: a retrospective series of 15 cases.
    Armengot-Carbo M; Velasco-Pastor M; Rodrigo-Nicolas B; Pont-Sanjuan V; Quecedo-Estebanez E; Gimeno-Carpio E
    Dermatol Ther; 2013; 26(3):257-9. PubMed ID: 23742285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issues.
    Wieder S; Maurer M; Lebwohl M
    Am J Clin Dermatol; 2015 Feb; 16(1):19-26. PubMed ID: 25452254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Omalizumab in the treatment of chronic urticaria: what's new in 2013?].
    Spoerl D; Harr T; Seebach JD
    Rev Med Suisse; 2014 Jan; 10(412-413):18-23. PubMed ID: 24558892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab in the treatment of chronic urticaria.
    Francés L; Leiva-Salinas M; Silvestre JF
    Actas Dermosifiliogr; 2014; 105(1):45-52. PubMed ID: 23938072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab therapy for chronic spontaneous urticaria: the Israeli experience.
    Rottem M; Segal R; Kivity S; Shamshines L; Graif Y; Shalit M; Kessel A; Panasoff J; Cohen S; Toubi E; Agmon-Levin N
    Isr Med Assoc J; 2014 Aug; 16(8):487-90. PubMed ID: 25269339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
    Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
    J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.